Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap Verweij

Showing results (1-10 of 234) with videos related to

Pageof 24
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 15, 2003
Ask the right questions!Jaap Verweij
Clinical Pharmacology and Therapeutics|March 7, 2003
Concern about similarity of manuscriptsJaap Verweij
Onkologie|August 8, 2012
Alveolar soft part sarcoma: should we be targeting the tumor or targeting the vasculature?Jaap Verweij
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
New targets in oncology drug developmentJaap Verweij
European Journal of Cancer (Oxford, England : 1990)|October 28, 2008
'No risk, no fun': challenges for the oncology phase I clinical trial time-performanceJaap Verweij
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Confusion caused by similarity in manuscript titlesJaap Verweij
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Ecteinascidin-743 (ET-743): early test or effective treatment in soft tissue sarcomas?Jaap Verweij
European Journal of Cancer (Oxford, England : 1990)|September 7, 2005
Pharmaceutical industry, investigators and institutions: Partners or tools?Jaap Verweij
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Adjuvant treatment of gastrointestinal stromal tumor: the proof, the pro, and the practiceJaap Verweij
European Journal of Cancer (Oxford, England : 1990)|January 22, 2005
Phase II trials of drug combinations: fairytales or fact?Jaap Verweij
Pageof 24

Showing results (1-10 of 234) with videos related to

Sort By:
Pageof 24
European Journal of Cancer (Oxford, England : 1990)|February 15, 2003
Ask the right questions!Jaap Verweij
Clinical Pharmacology and Therapeutics|March 7, 2003
Concern about similarity of manuscriptsJaap Verweij
Onkologie|August 8, 2012
Alveolar soft part sarcoma: should we be targeting the tumor or targeting the vasculature?Jaap Verweij
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
New targets in oncology drug developmentJaap Verweij
European Journal of Cancer (Oxford, England : 1990)|October 28, 2008
'No risk, no fun': challenges for the oncology phase I clinical trial time-performanceJaap Verweij
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Confusion caused by similarity in manuscript titlesJaap Verweij
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Ecteinascidin-743 (ET-743): early test or effective treatment in soft tissue sarcomas?Jaap Verweij
European Journal of Cancer (Oxford, England : 1990)|September 7, 2005
Pharmaceutical industry, investigators and institutions: Partners or tools?Jaap Verweij
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Adjuvant treatment of gastrointestinal stromal tumor: the proof, the pro, and the practiceJaap Verweij
European Journal of Cancer (Oxford, England : 1990)|January 22, 2005
Phase II trials of drug combinations: fairytales or fact?Jaap Verweij
Pageof 24